Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, FY2025
-10,859
Period ended Dec 31, 2025
Change on a year earlier
+15.3%
-9,415 in FY2024
History
19 years
Since FY2007
Sources
15
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net cash used in financing activities ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -10,859 | +15.3% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | -9,415 | -144.7% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 21,048 | -621.4% | Form 10-K (filed 2024-02-14) ↗ |
| FY2022 | Dec 31, 2022 | -4,037 | -51.2% | Form 10-K (filed 2023-02-09) ↗ |
| FY2021 | Dec 31, 2021 | -8,271 | +69.9% | Form 10-K (filed 2022-02-16) ↗ |
| FY2020 | Dec 31, 2020 | -4,867 | -69.1% | Form 10-K (filed 2021-02-09) ↗ |
| FY2019 | Dec 31, 2019 | -15,767 | -29.9% | Form 10-K (filed 2020-02-12) ↗ |
| FY2018 | Dec 31, 2018 | -22,490 | +241.1% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | -6,594 | +153.7% | Form 10-K (filed 2018-02-13) ↗ |
| FY2016 | Dec 31, 2016 | -2,599 | -31.1% | Form 10-K (filed 2017-02-14) ↗ |
| FY2015 | Dec 31, 2015 | -3,771 | +15.2% | Form 10-K (filed 2017-02-14) ↗ |
| FY2014 | Dec 31, 2014 | -3,274 | -220.1% | Form 10-K (filed 2017-02-14) ↗ |
| FY2013 | Dec 31, 2013 | 2,726 | +550.6% | Form 10-K (filed 2014-02-24) ↗ |
| FY2012 | Dec 31, 2012 | 419 | -162.2% | Form 10-K (filed 2013-02-27) ↗ |
| FY2011 | Dec 31, 2011 | -674 | -45.3% | Form 10-K (filed 2012-02-29) ↗ |
| FY2010 | Dec 31, 2010 | -1,232 | -39.1% | Form 10-K (filed 2011-02-25) ↗ |
| FY2009 | Dec 31, 2009 | -2,024 | -34.1% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | -3,073 | +15.2% | Form 10-K (filed 2010-03-01) ↗ |
| FY2007 | Dec 31, 2007 | -2,668 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Amgen Net cash used in financing activities ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_fin_cf
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.